Genmab — Juni 2018

[Legolas23]

The ghost study

[StockBull]

EU 1st line approval må også være tæt på ?

[StockBull]

Samt Maia, TV og Dara Q2 salgstal 17/7. GS conference 12-6.

[StockBull]

Så på et eller andet tidspunkt må TA gå i stærkt køb.

[E_L]

and maybe someday ALL, who knows.. https://www.nature.com/articles/s41409-018-0222-5

[Parasitism]

Godt nok en tam omsætning i dag.

[E_L]

the Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors started recruiting. That is pretty fast, was put on end march. https://clinicaltrials.gov/ct2/history/NCT03485209?A=1&B=4&C=merged

[E_L]

the TV trial for cervical cancer is the only one now not yet recruiting, should start soon also

[E_L]

Takeda also starts recruiting Ninlaro/Dara/Dex https://clinicaltrials.gov/ct2/history/NCT03439293?A=2&B=3&C=merged

[E_L]

Ha, I just mentioned ALL, coincidence: Daratumumab in Pediatric and Young Adult Participants...With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

[E_L]

also starts recruiting
https://clinicaltrials.gov/ct2/history/NCT03384654?A=6&B=7&C=merged

[E_L]

poor souls that have to take all the drugs in that 2nd cohort... lets hope it works…

[gdn55]

Hvad er det lige der har gjort Genmab så meget dårligere end for et år siden? Jeg følger med så godt jeg kan, og kan ikke se den er blevet dårligere, tværtimod. Hvad er det jeg forstår?

[gdn55]

ikke

[JKY_VH]

kursen

[JKY_VH]

952 med Nordea som største nettosælger.

[E_L]

A Phase II Study of Daratumumab plus Ibrutinib in Patients with Waldenstrom’s Macroglobulinemia https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-ii-study-of-daratumumab-plus-ibrutinib-in-patients-with-waldenstrom’s-macroglobulinemia

[Helge_LarsenPI-redaktør]

God morgen.

[transalp]

Go morgen..

[Schiff]

Weekenderne er det bedste ved at være Genmab aktionær